FACULTY

Faculty

At Westlake, we welcome talented people, outstanding scholars, research fellows, and young scientists from all backgrounds. We expect to have a community of 300 assistant, associate, and full professors (including chair professors), 600 research, teaching, technical support and administrative staff, and 900 postdoctoral fellows by 2026.

返回
Ju-Sheng Zheng, Ph.D.

Ju-Sheng Zheng, Ph.D.

Ju-Sheng Zheng, Ph.D.

School of Life Sciences

School of Medicine and School of Life Sciences

联系

网站: http://zheng.lab.westlake.edu.cn/

Biography

Ju-Sheng got his PhD degree in nutrition at Zhejiang University, Hangzhou, China (2009-2014). Within his PhD program, he received one year’s training in the Nutrition and Genomics Lab at Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in the USA (2012). He was also a Marie Skłodowska-Curie Individual Fellow supported by the European Commission and a postdoctoral researcher at the MRC Epidemiology Unit, University of Cambridge, UK (2015-2018).

Ju-Sheng joined the School of Life Sciences at Westlake University as a principal investigator and assistant professor in September 2018. He serves as associate editor for BMC Med and statistical editor for Asia Pac J Clin Nutr. He has published over 90 peer-reviewed papers in leading journals such as BMJ, Gut, Nat Commun, Diabetes Care, PLoS Med, Microbiome, BMC Med, Am J Clin Nutr, et al.  

History

2016

Marie Skłodowska-Curie Individual Fellow

Research

The major interest of Ju-Sheng’ current research is:

Precision nutrition: using novel study design (n-of-1 clinical trial) or wearable device (such as continuous glucose monitoring) to explore personalized response to diet and nutrition in the Chinese populations. Using multi-omics technologies to unveil the mechanism behind the link between nutrition and chronic diseases with large-scale human cohort data.

Computational Medicine: Use computational methods and multi-omics datasets (including nutrition biomarkers, genomics, metabolomics, microbiome and proteomics) within human cohorts to investigate the etiology of aging-related diseases or pregnancy-related outcomes, and to identify novel disease biomarkers and prioritize potential drug targets.

Gut microbiome epidemiology: Explore novel gut microbiome biomarkers for complex human diseases with multiple Chinese prospective cohort studies, and investigate the role of nutrition and host genetics in shaping gut microbiome, and how nutrition, genetics, and gut microbiome interact with each other to affect the host health.

Representative Publications

(* corresponding author)

1. Jiang Z, Zhuo LB, He Y, Fu Y, Shen L, Xu F, Gou W, Miao Z, Shuai M, Liang Y, Xiao C, Liang X, Tian Y, Wang J, Tang J, Deng K, Zhou H*, Chen YM*, Zheng JS*. The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases. Nat Commun2022, 13(1):3002.

2. Wang H, Gou W, Su C, Du W, Zhang J, Miao Z, Xiao C, Jiang Z, Wang Z, Fu Y, Jia X, Ouyang Y, Jiang H, Huang F, Li L, Zhang B*, Zheng JS*. Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults. Diabetologia 2022,65(7):1145-56.

3. Shuai M, Zhang G, Zeng F, Fu Y, Liang X, Yuan L, Xu F, Gou W, Miao Z, Jiang Z, Wang JT, Zhuo LB, Chen YM*, Ju F*, Zheng JS*. Human gut antibiotic resistome and progression of diabetes. Adv Sci 2022,e2104965. doi: 10.1002/advs.202104965

4. Shuai M, Fu Y, Zhong HL, Gou W, Jiang Z, Liang Y, Miao Z, Xu JJ, Huynh T, Wahlqvist ML*, Chen YM*, Zheng JS*. Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health. Gut 2022, gutjnl-2021-326298. doi: 10.1136/gutjnl-2021-326298.

5. Ma Y, Tian Y, Gou W, Miao Z, Yang M, Ordovas JM, Zheng JS*. Individual postprandial glycemic responses to diet in N-of-1 trials: Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR). J Nutr2021,151(10):3158-67.

6. Gou W, Ling CW, He Y, Jiang Z, Fu Y, Xu F, Miao Z, Sun TY, Lin JS, Zhu HL, Zhou H, Chen YM*, Zheng JS*. Interpretable machine learning framework reveals robust gut microbiome features associated with type 2 diabetes. Diabetes Care 2021, 44(2):358-366. doi: 10.2337/dc20-1536.

7. Miao Z, Lin JS, Mao Y, Chen GD, Zeng FF, Dong HL, Jiang ZL, Wang JL, Xiao CM, Shuai M, Gou W, Fu Y, Imamura F, Chen YM*, Zheng JS*. Erythrocyte n-6 polyunsaturated fatty acids, gut microbiota and incident type 2 diabetes: a prospective cohort study. Diabetes Care 2020, 43(10):2435-43.

8. Xu F, Fu Y, Sun TY, Jiang Z, Miao Z, Shuai M, Gou W, Ling CW, Yang J, Wang J*, Chen YM*, Zheng JS* The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome 2020, 8(1):145.

9. Fu Y, Gou W, Hu W, Mao Y, Tian Y, Liang X, Guan Y, Huang T, Li K, Guo X, Liu H*, Li D*, Zheng JS*. Integration of an interpretable machine-learning algorithm to identify early life risk factors of childhood obesity among preterm infants: a prospective birth cohort. BMC Med 2020, 18(1):184.

10. Zheng JS, Sharp SJ, Imamura F,  Rajiv C, Thomas GE, Marinka S, Sluijs I, van der Schouw YT, Agudo A, Aune D, Barricarte A, Boeing H, Chirlaque MD, Dorronsoro M, Freisling H, Fatoui DE, Franks PW, Fagherazzi G, Grioni S, Gunter MJ, Kyrø C, Katzke V, Kühn T, Khaw KT, Laouali N, Masala G, Nilsson PM, Overvad K, Panico S, Papier K, Quirós JR, Rolandsson O, Redondo-Sánchez D, Ricceri F, Schulze MB, Spijkerman AMW, Tjønneland A, Tong TYN, Tumino R, Weiderpass E, Danesh J, Butterworth AS, Riboli E, Forouhi NG*, Wareham NJ. Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: The EPIC-InterAct case-cohort study in eight European countries. BMJ 2020;370:m2194.


Full list of publications:

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/?term=ju-sheng+zheng+or+jusheng+zheng

Lab website: http://zheng.lab.westlake.edu.cn/

Contact Us

E-mailzhengjusheng@westlake.edu.cn

Tel: +86-0571-86915303